Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Libor Fila

3PUBLICATIONS

8CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Cancer cell biologyMedical genetics (excl. cancer genetics)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 13, 2025

Comparison of the Effect of CFTR Modulators <i>elexacaftor</i>/<i>tezacaftor</i>/<i>ivacaftor</i> and <i>lumacaftor</i>/<i>ivacaftor</i> via Serum Human Epididymis Protein 4 Concentration in <i>p.Phe508del-CFTR</i> Homozygous Cystic Fibrosis Patients.

Marianna Pócsi, Libor Fila, Csaba Péterfia

|Dec 12, 2017

What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.

Jaroslav Nunvar, Vaclav Capek, Karel Fiser

|Apr 02, 2017

Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.

Libor Fila, Pavel Dřevínek

Pageof 1

Frequent Collaborators

1 joint publications

Karel Fiser

1 joint publications

Pavel Drevinek

1 joint publications

Marianna Pócsi

1 joint publications

Csaba Péterfia

1 joint publications

György Panyi

1 joint publications

István Balogh

1 joint publications

Milan Macek

1 joint publications

Béla Nagy

Frequent Collaborators

1 joint publications

Karel Fiser

1 joint publications

Pavel Drevinek

1 joint publications

Marianna Pócsi

1 joint publications

Csaba Péterfia

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on : Apr 18, 2025

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on : Apr 18, 2025

See more related videos